**Question:** Pralidoxime is ineffective in case of which poisoning?

**Core Concept:** Pralidoxime is a specific antidote for organophosphate poisoning, which is a type of pesticide. Organophosphates interfere with acetylcholinesterase enzyme, leading to increased acetylcholine levels and various symptoms including respiratory distress, cardiovascular collapse, and central nervous system depression.

**Why the Correct Answer is Right:** Pralidoxime is effective in treating poisoning caused by organophosphates. It acts as a reactivator of acetylcholinesterase, restoring the enzyme's activity and reducing the excessive acetylcholine levels, thereby alleviating organophosphate poisoning symptoms.

**Why Each Wrong Option is Incorrect:**
A. Organophosphate-induced delayed neuropathy (OPIDN) is a long-term complication from organophosphate exposure. Pralidoxime is not indicated for treating OPIDN, as it primarily affects the nervous system and does not target the underlying damage.
B. Organophosphate poisoning involves acetylcholinesterase inhibition, which leads to excessive acetylcholine levels. Pralidoxime reactivates the enzyme, making it right for treating organophosphate poisoning.
C. Pralidoxime is not effective for treating organophosphate-induced respiratory distress, cardiovascular collapse, and central nervous system depression.
D. Pralidoxime does not address the issue in poisoning caused by organophosphate-induced acute neuropathy (OPAN), another long-term complication distinct from OPIDN.

**Clinical Pearl:** In cases of organophosphate poisoning, promptly administering atropine (anticholinergic) and pralidoxime in combination is essential to manage the respiratory and cardiovascular effects of excessive acetylcholine levels. However, pralidoxime is not effective in treating OPIDN, OPAN, or other complications from organophosphate exposure.

**Correct Answer:** D. Organophosphate-induced delayed neuropathy (OPIDN)

---

If the poisoning is due to organophosphate-induced delayed neuropathy (OPIDN), the correct antidote to treat the poisoning is **not** Pralidoxime, as it is not effective in addressing the underlying damage caused by OPIDN. In this context, Pralidoxime is used for treating the acute effects of organophosphate poisoning, such as respiratory distress, cardiovascular collapse, and central nervous system depression. However, OPIDN is a different complication resulting from chronic organophosphate exposure and requires different treatment strategies.